Skip to main content
OpenTrials
Completed

NCT Number: NCT05429489

Erector Spinae Plane Block Versus General Anesthesia in Breast Cancer Surgeries

This study aims at comparing the analgesic efficacy and safety of bilevel erector spinae versus single level versus general anesthesia for breast cancer surgeries

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Walaa Y Elsabeeny

Cairo, 11796, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female
  • Diagnosed with breast cancer

Exclusion criteria

  • Patient refusal
  • coagulation defects
  • bone metastases
  • abnormal kidney and/or liver function tests

Treatment and study plan

Bilevel erector spinae plane block

Procedure

Bilevel erector spinae plane block at 3rd and 5th thoracic vertebral levels

Single level erector spinae plane block

Procedure

Single level erector spinae plane block at 5th thoracic vertebrae

intravenous morphine

Drug

Intravenous morphine 0.1 mg/kg

Primary outcomes

  1. Total analgesic requisite

    Time frame: First 24 hours postoperatively

    total postoperative morphine consumption

Sponsors and collaborators

Lead sponsor

National Cancer Institute, Egypt

Other

Registry information

Official study title

Comparison of the Efficacy of Bilevel Erector Spinae Plane Block and Single Level Erector Spinae Plane Block Versus General Anesthesia in Breast Cancer Surgeries

Important dates

Study start
2022
Primary completion
2023
Study completion
2024
First posted
Jun 23, 2022
Registry last updated
Jan 23, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.